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Introduction
Traditional medicine practice has been around for centuries
and still remain very common in the developing world. It is
estimated that about 80% or more of the world’s population
rely primarily on traditional medicine for their healthcare
(Cunningham 1993). The huge reliance on traditional
medicine, especially in rural areas, has been attributed to
both economic and cultural factors (Aketch 1992, Okafor
and Ham 1999). In Nigeria, the case is no different; it has
been an age-old practice. Many people, both in rural and
urban areas, consult traditional healers, even when
conventional drugs and Western healthcare facilities are
affordable and accessible. Despite its perceived short-
comings, traditional medicine practice plays an enormous
role in primary healthcare systems.
Medicinal plants have become the subject of very intense
pharmacological study in recent years. This is due to the
recognised fact that medicinal plants have provided a source
of inspiration for novel drug compounds, as plant-derived
medicines have made large contributions to human health
and well-being. In the development of new drugs, their role
is two-fold — as the base for the development of new
medicine, a natural blueprint for the development of new
drugs, or as a phytomedicine to be used for the treatment
of disease (Iwu et al. 1999). As a result, there is a need
to screen more medicinal plants for bioactive compounds.
Infectious disease accounts for approximately one-half of
all deaths in tropical countries (Iwu et al. 1999). Factors
such as inadequate sanitation, poor hygiene and over-
crowded living conditions have all been linked with the
prevalence of bacterial infections in the developing world
(Rasoanaivo and Ratsimamanga-Urveg 1993). In Nigeria,
medicinal plants have always been employed for the treat-
ment of bacterial infections and inflammatory conditions
(Agoha 1974, Sofowora 1982, Iwu 1993).
Malaria is the most widespread insect-borne disease. It
kills between one and two million people every year, with
as many as 300–500 million people being infected (Saxena
et al. 2003). Malaria is a typical example of a disease that
affects the efficiency of individuals, families and the
community. It is prevalent in the poorer and less-developed
countries of the world, with Africa facing its greatest impact
(WHO 1993). Plants have always been a good source of
chemotherapeutic agents. The first antimalarial drug was
quinine, isolated from the bark of Cinchona species
(Rubiaceae), and it is one of the oldest and most important
antimalarial drugs today. Chloroquine, another antimalarial
drug, was synthesised, and until recently, this was the only
drug used for the treatment of malaria (Bharel et al. 1996).
The malarial parasite Plasmodium falciparum has become
resistant to chloroquine (Mukherjee 1991). Another
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Petroleum ether, dichloromethane and 80% ethanol
extracts of 15 plant species from Nigeria were screened
for in vitro antibacterial, anti-inflammatory and
antimalarial activities. Antibacterial activity was tested
using agar diffusion and microtitre serial dilution tests.
Most antibacterial activity was against Gram-positive
bacteria, with Staphylococcus aureus being the most
susceptible of the bacteria tested. The highest activity
was found in both petroleum ether and dichloromethane
extracts of Mallotus oppositifolius leaves, petroleum
ether, dichloromethane and ethanolic extracts of
Newbouldia laevis roots, and ethanolic extracts of
Morinda lucida and Canthium subcordatum roots.
Against the Gram-negative Escherichia coli, the highest
activity was found in dichloromethane root extracts of
Newbouldia laevis, ethanolic root extracts of
Phyllanthus amarus, Mallotus oppositifolius and
Canthium subcordatum. A total of 60 plant extracts was
screened for antiplasmodial activity. A chloroquine
sensitive strain of Plasmodium falciparum (D10) was
used. In the assay, the parasite lactate dehydrogenase
(pLDH) activity was used to measure parasite viability.
Eleven extracts showed promising activity, with IC50
ranging from 2.5µg ml–1 to 13.8µg ml–1. Cyclooxygenase
(COX-1 and COX-2) assays were used to test for anti-
inflammatory activity. All the plant species, except for
two, showed anti-inflammatory activity, with activity
mostly in petroleum ether and dichloromethane extracts.
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important antimalarial drug from plants is artemisinin,
isolated from the Chinese plant Artemisia annua (Klayman
1985). As plants have over the years proved to be a good
source of chemotherapeutic agents, researchers are now
actively investigating them for new active antimalarial drugs.
The present work was geared towards screening some
medicinal plants used in traditional medicine for antibac-
terial, anti-inflammatory and antimalarial activity, and vali-
dation of the plants used in traditional medicine.
Materials and Methods
Plant material
Plant material was collected between May and June 2002
from Oraifite in Anambra state, south-eastern Nigeria.
Identification of the plants was confirmed by Prof. Jonathan
Okafor of Tree Crops and Tropical Ecology Consultancy,
Nigeria. Voucher specimens were deposited in the Enugu
State Herbarium (Table 1).
Preparation of plant extracts
Plant parts were air-dried for two weeks and then powdered.
Plant material (10g) was extracted sequentially with 150ml
each of petroleum ether (PE) and dichloromethane (DM)
and then with 80% ethanol (ET), using a sonication bath
for 1h. Crude extracts obtained were filtered and dried under
reduced pressure at 30°C.
Antibacterial activity
Disc diffusion assay
The disc diffusion assay was used to determine the inhi-
bition of bacterial growth by the plant extracts (Rasoanaivo
and Ratsimamanga-Urverg 1993). The Gram-positive
Bacillus subtilis (ATCC 6051), Staphylococcus aureus
(ATCC 12600), Micrococcus luteus (ATCC 4698) and Gram-
negative Klebsiella pneumonae (ATCC 13883) and
Escherichia coli (ATCC 11775) were used as test organisms.
Bacteria were maintained at 4°C on nutrient agar (NA)
plates. Base plates were prepared by pouring 10ml Mueller-
Hinton (MH) agar into sterile Petri dishes (90mm) and
allowing them to set. Molten MH agar held at 48°C was
inoculated with a broth culture (106–108 bacteria per
millilitre) of the test organism and poured over the base
plates, forming a homogenous top layer. Plant extracts were
dissolved in the extracting solvents at a concentration of
100mg ml–1 and thereafter 10µl (1mg of plant extract per
disc) were dispensed on a 6mm sterile paper disc (Whatman
No. 3). The discs were air-dried and placed into the seeded
top layer of the MH agar plates. Each extract was tested
in quadruplicate (four discs per plate), with a neomycin
(500µg ml–1) disc as reference or positive control. Air-dried
solvent-saturated (PE, DM and ET) discs were used as
negative controls. The plates were evaluated after
incubation at 37°C for 18h, after which the zones of inhibition
around each disc were measured. Antibacterial activity was
measured as a ratio of the inhibition zone of bacterial growth
(mm) produced by the plant extract and the inhibition zone
around the neomycin standard (Vlietinck 1997). The activity
of neomycin was included in this equation to adjust for
plate-to-plate variations in the sensitivity of a particular
bacterial strain (Rabe and Van Staden 1997). Results given
are means of two experiments.
Microdilution assay
The microtitre bioassay (Eloff 1998) was used to determine
the Minimal Inhibitory Concentration (MIC) for the plant
extracts that inhibited bacterial growth or showed
bacteriostatic effect in the disc-diffusion assay. Plant extracts
(both polar and non-polar) were made up to 50mg ml–1 with
25% ethanol. Plant extracts (100µl) were two-fold serially
diluted with distilled water in 96-well microplates to give
concentrations from 12.5–0.098mg ml–1. Overnight MH broth
cultures (grown at 37°C in a water bath with continuous
shaking) of the test organisms were diluted 100-fold with MH
broth, and 100µl of the resulting bacterial culture was added
to each well. Neomycin (100µg ml–1) was used as a positive
control for each bacterium, with solvent and bacteria-free
wells being included as negative controls. Microplates were
covered and incubated overnight at 37°C. To indicate bacterial
growth, 40µl of 0.2mg ml–1 p-indonitritetrazolium violet (INT)
was added to each well and incubated at 37°C for 30min.
The colourless tetrazolium salt acts as an electron acceptor,
and is reduced to a red-coloured formazan product by
biologically active organisms (Eloff 1998). Clear wells with
INT after incubation indicate inhibition of bacterial growth.
MIC values were recorded as the lowest concentration of
extract that completely inhibited bacterial growth.
Cyclooxygenase (COX) assay
COX-1 and COX-2 assays were carried out, as described
by Jäger et al. (1996) and Noreen et al. (1998). Inhibition
was measured by the reduction of prostaglandin formation
in comparison to control. Human recombinant COX-2 with
70% purity, isolated from the Baculovirus over-expression
system, was purchased from Sigma-Aldrich (USA). COX-1
with 95% purity, isolated from ram seminal vesicles, was
also purchased from Sigma and stored at –70°C. Enzyme
(60µl) was added to the sample solutions (20µl, 2.5µl of
ethanolic plant extract + 17.5µl of distilled water; final
concentration of 250µg ml–1). Each aliquot (10µl) of both
enzymes containing three units was prepared and incubated
at room temperature for 5min. The reaction was started by
adding 20µl of [1-14C] arachidonic acid (30µM). Samples
were then incubated at 37°C (10min for COX-2 and 8min
for COX-1) and the reaction was terminated by adding 10µl
2M HCl. Results are the mean of two experiments (each
experiment in duplicate). Indomethacin was used as a
positive control at a concentration of 20µM for COX-1 and
200µM for COX-2.
Antiplasmodial assay
All experiments were performed in duplicate on a single
occasion using a chloroquine-sensitive strain of Plasmodium
falciparum (D10). The parasites were continuously cultured,
according to the methods described by Trager and Jensen
(1976), and the parasite lactate dehydrogenase (pLDH)
activity was used as a measure of parasite viability, as
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Family name Scientific name and Local name Plant part used Medicinal uses Reference
voucher specimen
Apocynaceae Hedranthera barteri Utumbekwu Malaria, hiccups Traditional healers
(Hook. f.) Pichon
EFH9002
Holarrhena floribunda Mba Roots Dysentery, fever and malaria Traditional healers
(G. Don) EFH9001
Picralima nitida Agbudugbu Seeds, stem Malaria, sleeping sickness, Iwu (1993) 
(Stapf) EFH9008 and roots local analgesic, arthritis, Traditional healers
cough, aphrodisiac and 
diabetes
Rauvolfia vomitoria Akanta Roots, stem Fever, sedative in maniac Iwu (1993)
(Afzel.) EFH9015 and leaves syndromes, emetic 
Strophanthus Agbulugbu Seeds and Cardiac insufficiency, Iwu (1993) 
hispidus (DC.) roots arrow poison Traditional healers
EFH9011
Bignoniaceae Newbouldia laevis Ogilisi Leaves, Malaria and fever, scorpion Iwu (1993),
(Seem.) EFH9006 stem bark, and snake bite, febrifuge, Gormann et al.
roots and fruits wound dressing, stomach- (2003), Houghton
ache, coughs,STDs, aphrodisiac, and Osibogun
migraine, ear-ache, eye-disease, (1993)
breast cancer, dysentery,
rheumatoid arthritis, epilepsy
and skin infections
Caesalpinaceae Cassia occidentalis Nsiwu muo Leaves Malaria and fever Traditional healers
L. EFH9009 
Euphorbiaceae Mallotus oppositifolius Okpo-biriba Leaves, fruits Dysentery, haemorrhage, Traditional healers
(Geiseler) Müll. Arg. and roots stomach-ache and chest pains
EFH9016
Phyllanthus amarus Nke kwo Leaves and Viral hepatitis, jaundice, Iwu (1993),Okafor
(Schumach. and Thonn.) nwa na azu roots gonorrhea, frequent and Ham (1999)
EFH9014 menstruation, diabetes,
stomach-ache, cold, malaria,
skin sores, swelling and
itchiness
Labiatea Hyptis suaveolens Nsiwu muo Leaves and Respiratory track infections, Iwu (1993) 
(L.) POIT EFH9010 stem cold, skin diseases, female
hygiene
Loganiaceae Anthocleista vogelii Odudummiri Stem bark and Inflammation, diabetes, Iwu (1993) 
(Planch.) EFH9013 leaves wound dressing, venereal Traditional healers
diseases 
Polygalaceae Carpolobia alba Okokpa ofia Roots and fruits General tonic, cough, indiges- Iwu (1993)  
(G. Don) EFH9012 tion, externally for pains,
aphrodisiac
Rubiaceae Canthium subcordatum Okpu-aruru Roots and Malaria and fever Traditional healers
(DC.) EFH9007 stem bark
Morinda lucida Isi-mkpi, Njisi, Roots, stem bark Fever, malaria and pains, Iwu (1993), Awe
(Benth. syn.) Ezeogwu and leaves ulcerating abscess, and Makinde
EFH9005 helminthiasis, trypanosomiasis (1998), Okpekon et 
al. (2004)
Nauclea latifolia Ubulu inu Roots and Malaria, fever teas, inflam- Iwu (1993)  
(Smith) EFH9004 stem bark mation, stomach-ache
Uvaria chamae Uda-ani Leaves, roots Haemorrhoids, malaria, Madubunyi et al.
(P. Beauv.) EFH9003 and stem bark coughs and liver, kidney (1996), Langason
and bladder diseases. As et al. (1994) and 
a febrifuge and purgative, traditional healers
peptic ulcers, colic, dysentery,
gastric and abdominal pain
Table 1: Selected Nigerian medicinal plants investigated for antibacterial, anti-inflammatory and antimalarial activities
described by Makler et al. (1993). The results are expressed
as the average percentage parasite viability at three different
concentrations of the plant extracts: 25µg ml–1, 12.5µg ml–1
and 6.25µg ml–1. A full-dose response experiment (concen-
tration range of 100–0.20µg ml–1) was performed on extracts
that showed 50% parasite inhibition at 6.25µg ml–1. The
50% inhibitory concentration (IC50) values for these extracts
were obtained from the dose-response curves, using non-
linear dose-response curve fitting analysis with GraphPad
Prism Version 3.00 software.
Results
Antibacterial activity
Antibacterial activity detected using the disc diffusion
assay and MIC values of crude extracts of different plant
parts of different species is presented in Table 2. Most
activity was detected in 80% ethanol extracts, followed by
dichloromethane extracts; very little activity was detected
in the petroleum ether extracts. Of the 57 extracts
screened, 27 were active against E. coli, 22 against M.
luteus, 14 against K. pneumonae, 32 against S. aureus
and 29 against B. subtilis.
Anti-inflammatory activity
The effect of different plant extracts on the inhibition of
prostaglandin synthesis by inhibiting COX-1 and COX-2
activity is presented in Table 3. Of the 66 extracts tested,
18 petroleum ether extracts, 16 dichloromethane extracts,
and one 80% ethanol extract showed high inhibitory activity
(>70%) against COX-2. These active extracts were
subsequently screened for COX-1 inhibitory activity, and
many of them showed less than 60% inhibitory activity
against COX-1.
Antiplasmodial activity
The parasite viability at three different concentrations of the
extracts, and the IC50 values of the most active extracts, are
presented in Table 4. Out of the 60 extracts that were tested,
11 showed ≥50% parasite inhibition at 6.25µg ml–1. The IC50
values of these active extracts were then determined. The
majority of the IC50 values were less than 6.3µg ml
–1, except
for petroleum ether extract of A. vogelii roots and dichloro-
methane extracts of M. lucida and C. alba roots.
Discussion
Antibacterial activity
The Gram-positive bacterium S. aureus was the most
susceptible, while few extracts showed activity against the
Gram-negative bacteria used. Gram-negative bacteria are
generally more difficult to inhibit, due to the presence of
a thick murin layer that tends to prevent the entry of inhi-
bitors (Martin 1995, Vlietinck et al. 1995).
The DM extracts of N. laevis roots exhibited a broad-
spectrum activity, with the highest activity being against S.
aureus (1.96) followed by E. coli (1.29). Naphthoquinones,
isolated from a DM extract of N. laevis roots, were shown
to have antibacterial activity against B. subtilis and E. coli
(Gafner et al. 1996). In the present study, the antibacterial
activity against M. luteus and S. aureus may be due to the
presence of these compounds in the root extracts. The 80%
ET extracts of P. amarus, M. oppositifolius, S. hispidus and
C. subcordatum roots also exhibited high activity against
E. coli (Table 2).
Previous studies showed mostly polar extracts from P.
amarus to possess anti-viral (Venkateswaran et al. 1987,
Thyagarajan et al. 1988, Blumberg et al. 1989, Niu et al.
1990, Unander et al. 1990, Thamlikitkul et al. 1991, Lee et
al. 1996, Ott et al. 1997, Notka et al. 2003), antimutagenic,
antitumour, anticarcinogenic (Rajeshkumar et al. 2002,
Sripanidkulchai et al. 2002) and anti-inflammatory properties
(Kiemer et al. 2003, Raphael and Kuttan 2003), and to have
contraceptive effects (Rao and Alice 2001). In the present
study, both the leaf and root extracts were screened for
antibacterial, anti-inflammatory and antiplasmodial activities.
The 80% ET, DM and PE extracts of the root and 80% ET
extracts of the leaf were active against one or more of the
bacteria screened.
Anti-inflammatory activity
Extracts that exhibited more specific inhibitory activity
against COX-2 are mostly PE and DM extracts. An
exception was the 80% ET extract of C. occidentalis roots.
This is the first time anti-inflammatory activity has been
reported for C. subcordatum, C. lutea, N. latifolia, N. laevis,
C. occidentalis and H. suaveolens. However, traditional
healers mainly use water in the preparation of plant extracts.
The inhibitory activity of the PE and DM extracts may be
immaterial in terms of validation of the use of these plants
in traditional medicine. Nevertheless, it does establish the
existence of anti-inflammatory properties in these plants.
These findings can possibly provide leads towards discovery
of more specific COX-2 inhibitors.
Antiplasmodial activity
The PE extracts of A. vogelii roots and DM extracts of M.
lucida roots were only partially soluble, which probably
contributed to the non-reproducible results. There has been
extensive reporting on the antiplasmodial activity of M.
lucida (Makinde and Obih 1985, Obih et al. 1985). Anthro-
quinones with antiplasmodial activity against P. falciparum
have been isolated from the stem bark and roots of M.
lucida (Koumaglo et al. 1992, Sittie et al. 1999). This study
supports the findings of these previous researchers that
this plant does possess antimalarial activity. Traditional
healers boil the roots in water and use the filtrate to treat
malaria. However, the 80% ET extract did not exhibit
antiplasmodial activity. According to Awe et al. (1998), the
methanolic extract of the leaves displayed antipyretic
activity, and this could mean that the local peoples actually
use it to treat fever, which is one of the symptoms of malaria.
Awe and Makinde (1998) also reported antiplasmodial
activity of PE extract of M. lucida leaves against P.
falciparum. In the present study, the PE extract of the roots
did not exhibit antiplasmodial activity. This could be due to
South African Journal of Botany 2005, 71(3&4): 316–325 319
Chukwujekwu, Van Staden and Smith320
Table 2: Determination of the antibacterial activitya of some Nigerian medicinal plants with the disc-diffusion (D. Dif.) and microdilution
assays (MIC expressed in mg ml–1). Values are the mean ± SEM of results obtained from two assays
Plant species Plantb Extractc Bacteria testedd
part E.c.– M.l.+ K.p.– S.a.+ B.s.+
D.Dif. MIC D.Dif. MIC D.Dif. MIC D.Dif. MIC D.Dif MIC
H. barteri L PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.00 – 0.00 – 0.12 ± 0.2 3.125 0.12 ± 0.00 1.560 0.00 –
H. floribunda R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.00 – 0.48 ± 0.01 0.780 0.00 – <0.10 1.560 <0.10 1.560
P. nitida R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.71 ± 0.17 <0.098 0.00 – <0.10 1.560 <0.10 3.125
ET Bst. 3.125 0.68 ± 0.00 0.195 0.00 – 0.25 ± 0.01 0.780 0.16 ± 0.08 3.125
R. vomitoria R PE Bst. 3.125 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.25 ± 0.02 1.560 0.85 ± 0.01 6.250 0.00 – <0.10 1.560 0.84 ± 0.04 3.125
ET 0.00 – 0.18 ± 0.00 0.195 Bst. 3.125 0.14 ± 0.01 1.560 0.25 ± 0.00 0.780
L PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
H. hispidus R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.71 ± 0.07 0.780 <0.10 1.560 0.00 – 0.29 ± 0.00 0.780 <0.10 0.780
L PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
N. laevis R PE <0.10 6.250 0.53 ± 0.01 6.250 0.00 – 1.02 ± 0.03 1.560 0.67± 0.00 1.560
DM 1.29 ± 0.14 6.250 0.51 ± 0.07 3.125 0.00 – 1.96 ± 0.02 0.780 0.68 ± 0.01 6.250
ET 0.27 ± 0.03 0.390 0.00 – 0.00 – 1.00 ± 0.01 1.560 0.23 ± 0.00 1.560
C. occidentalis R PE 0.00 – 0.00 – <0.10 3.125 0.56 ± 0.00 3.125 0.00 –
DM 0.50 ± 0.04 6.250 0.27 ± 0.12 1.560 0.00 – <0.10 3.125 0.33 ± 0.01 3.125
ET 0.00 – 0.00 – 0.00 – 0.13 ± 0.02 <0.098 0.16 ± 0.00 0.780
L PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM Bst. 3.125 <0.10 3.125 0.00 – 0.00 – 0.00 –
ET 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
M. oppositifolius R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.80 ± 0.01 0.390 0.00 – 0.00 – <0.10 1.560 0.00 –
L PE 0.00 – 0.16 ± 0.00 0.195 0.00 – 1.89 ± 0.27 <0.098 0.40 ± 0.01 1.560
DM Bst. 3.125 0.36 ± 0.01 6.250 0.00 – 2.36 ± 0.01 <0.098 0.43 ± 0.01 0.780
ET Bst. 1.560 0.48 ± 0.03 0.780 0.00 – 0.50 ± 0.00 0.390 0.36 ± 0.02 0.780
P. amarus R PE 0.00 – 0.00 – 0.14±0.00 >12.500 0.32 ± 0.00 6.250 0.00 –
DM Bst. 1.560 0.00 – 0.00 – 0.57 ± 0.03 1.560 0.00 –
ET 0.83 ± 0.02 0.780 0.61 ± 0.00 0.195 0.00 – 0.50 ± 0.20 0.195 <0.10 0.780
L PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET Bst. 0.195 0.00 – Bst. 0.780 0.21 ± 0.12 0.390 <0.10 1.560
H. suaveolens R PE Bst. 3.125 0.00 – <0.10 >12.500 <0.10 1.560 <0.10 3.125
DM 0.27 ± 0.01 0.390 0.00 – 0.00 – <0.10 0.780 0.19 ± 0.02 6.250
ET 0.00 – 0.00 – Bst. 1.560 0.00 – <0.10 3.125
L PE Bst. 0.195 0.14 ± 0.01 6.250 Bst. >12.500 0.34 ± 0.01 1.560 0.23 ± 0.00 6.250
DM Bst. 0.390 0.00 – 0.00 – 0.14 ± 0.01 1.560 <0.10 6.250
ET Bst. 0.390 0.53 ± 0.00 0.780 0.00 – 0.00 – Bst. 1.560
C. subcordatum R PE 0.00 – 0.00 – <0.10 6.250 0.00 – 0.00 –
DM 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
ET 0.83± 0.00 0.390 <0.10 0.390 0.17± 0.03 0.780 0.67 ± 0.00 0.195 <0.10 0.780
M. lucida R PE 0.00 – 0.00 – 0.00 – 0.33 ± 0.02 0.780 0.16 ± 0.20 1.560
DM Bst. 0.195 0.29 ± 0.01 0.780 Bst. 1.560 0.17 ± 0.01 0.195 0.19 ± 0.00 0.780
ET Bst. 0.390 0.25 ± 0.00 0.780 0.00 – 0.64 ± 0.00 0.390 0.13 ± 0.01 0.195
N. latifolia R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM Bst. 3.125 <0.10 >12.500 <0.10 12.500 Bst. 0.780 <0.10 12.50
ET Bst. 0.195 <0.10 0.195 Bst. 0.390 0.00 – 0.10 0.780
a number of factors, such as variation in the distribution of
the active compound within the plant, and seasonal variation.
The DM extract of C. alba roots showed high antiplas-
modial activity initially, although the IC50 value was greater
than what would be expected. A possible explanation for
this is that the active compounds are not stable in solution
and a fresh stock solution needs to be made up on the
day of the experiment. Due to the limited supply of plant
material, this was not feasible. This is the first report on
the antimalarial properties of this plant.
The PE extract of H. suaveolens leaves had the lowest
IC50 value (2.54µg ml
–1), and DM extract of its leaves also
displayed good antiplasmodial activity. Both DM and PE
extracts of its roots exhibited much less antiplasmodial
activity at 6.25µg ml–1. This could, however, be attributed
to variation in the distribution of the active compound(s)
within the whole plant. Traditional healers use the leaves
topically by soaking them in water and then bathing in the
water. This finding will be duly communicated back to the
traditional healers who identified the plant.
Both DM and 80% ET extracts of R. vomitoria roots
displayed good antiplasmodial activity, with IC50 of 4.78µg
ml–1 and 5.33µg ml–1 respectively. This plant has been inves-
tigated for its anti-inflammatory (Kweifiookai et al. 1995)
and anti-psychotic properties (Obembe et al. 1994) and its
effect in the treatment of haemorrhoids and anal prolapse
(Olapade 1993). In the literature, there is only one report
on antimalarial and antipyretic properties of R. vomitoria
(Amole et al. 1998).
The PE extract of P. amarus leaves was another extract
that showed significant antiplasmodial activity. As mentioned
earlier, most ethnopharmacological studies on this plant
Plant species Plantb Extractc Bacteria testedd
part E.c.– M.l.+ K.p.– S.a.+ B.s.+
D.Dif. MIC D.Dif. MIC D.Dif. MIC D.Dif. MIC D.Dif MIC
U. chamae R PE 0.00 – 0.00 – 0.00 – 0.00 – 0.00 –
DM Bst. 3.125 0.00 – 0.00 – Bst. 3.125 Bst. 3.125
ET Bst. 0.098 <0.10 0.195 <0.10 3.125 0.28 ± 0.01 0.390 0.00 –
Neomycin 0.062 0.032 0.018 0.032 0.018
a The antibacterial activity is expressed as the ratio of the inhibition zone of the extract (100mg ml–1) to the inhibition zone of the reference
(neomycin, 500µg ml–1)
b Plant part: R, roots; L, leaves 
c Extract: PE, petroleum ether; DM, dichloromethane; ET, 80% ethanol
d Bacteria: E.c., Escherichia coli; M.l., Micrococcus luteus; K.p., Klebsiella pneumonae; S.a., Staphylococcus aureus; B.s., Bacillus
subtilis
Bst., bacteriostatic effect; –, extract not tested
Table 2: (cont.)
Plant species Plant part COX-2 COX-1
PE extract DM extract ET extract PE extract DM extract ET extract
H. barteri L 29 ± 4.2 37 ± 4.6 33 ± 7.0 – – –
H. floribunda R 61 ± 4.2 86 ± 7.0 34 ± 1.4 – 46 ± 2.8 –
P. nitida R 43 ± 1.7 45 ± 6.1 17 ± 2.5 – – –
R. vomitoria R 77 ± 1.4 67 ± 3.5 31 ± 2.1 81 ± 2.8 71 ± 0.7 –
L 59 ± 2.1 81 ± 2.6 23 ± 3.4 – 99 ± 0.7 –
S. hispidus R 74 ± 2.8 71 ± 4.2 41 ± 2.7 48 ± 2.1 67 ± 0.8 –
L 74 ± 1.4 71 ± 2.8 45 ± 0.9 64 ± 4.2 63 ± 3.5 –
N. laevis R 86 ± 1.9 78 ± 1.4 50 ± 5.6 55 ± 2.3 44 ± 4.9 –
C. occidentalis R 89 ± 1.6 81 ± 4.2 74 ± 5.6 99 ± 0.0 84 ± 0.9 46 ± 1.7
L 86 ± 1.9 82 ± 3.5 19 ± 4.2 92 ± 2.1 58 ± 1.5 –
M. oppositifolius R 79 ± 1.4 74 ± 2.8 37 ± 3.1 83 ± 5.6 49 ± 2.1 –
L 92 ± 2.8 91 ± 3.5 59 ± 1.7 91 ± 2.9 97 ± 3.5 –
P. amarus R 85 ± 0.8 76 ± 0.7 42 ± 2.6 78 ± 7.4 36 ± 3.4 –
L 78 ± 2.9 81 ± 1.4 34 ± 0.7 91 ± 2.1 96 ± 2.1 –
H. suaveolens R 72 ± 0.2 81 ± 2.1 31 ± 5.6 66 ± 0.8 50 ± 0.6 –
L 72 ± 6.1 83 ± 0.4 20 ± 5.6 67 ± 7.1 67 ± 6.3 –
A. vogelii R 76 ± 0.9 86 ± 1.7 50 ± 1.6 42 ± 1.8 53 ± 2.6 –
C. alba R 78 ± 4.2 89 ± 1.3 23 ± 4.9 51 ± 1.8 50 ± 3.9 –
C. subcordatum R 72 ± 1.4 58 ± 0.7 53 ± 1.9 45 ± 0.0 – –
M. lucida R 83 ± 0.6 65 ± 2.8 36 ± 4.2 36 ± 0.0 – –
N. latifolia R 81 ± 1.3 62 ± 3.8 15 ± 7.8 66 ± 0.7 – –
U. chamae R 82 ± 4.2 78 ± 5.6 12 ± 7.3 48 ± 1.7 71 ± 3.3 –
Table 3: Percentage prostaglandin synthesis inhibition exhibited by extracts (250µg ml–1) of some plants used for medicinal purposes in
Nigeria. Percentage prostaglandin synthesis inhibition by indomethacin in COX-1 was 70–82%, and in COX-2 it was 58–72%. Extracts
with more specific COX-2 inhibitors are in bold; L, leaves; R, roots; PE, petroleum ether; DM, dichloromethane; ET, 80% ethanol
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Plant name Plant part Extract % Parasite viability
25µg ml–1 12.5µg ml–1 6.25µg ml–1 IC50 (µg ml
–1)
H. barteri L PE 21.86 58.79 72.36 –
DM 5.75 41.26 80.72 –
ET 48.31 87.37 91.11 –
P. nitida R PE 89.60 104.06 88.80 –
DM 6.35 78.06 82.99 –
ET 0 0 42.12 6.29
R. vomitoria R PE 68.90 97.01 99.78 –
DM 0.84 5.18 13.50 4.78
ET 0 6.79 36.66 5.33
L PE 15.94 80.43 77.05 –
DM 23.44 81.94 89.69 –
ET 79.31 88.53 83.72 –
S. hispidus R PE 8.23 22.87 71.56 –
DM 15.79 67.55 92.11 –
ET 82.68 110.77 97.74 –
L PE 5.28 12.70 47.70 –
DM 49.86 89.22 91.46 –
ET 77.30 95.95 104.90 –
N. laevis R PE 19.30 82.73 77.60 –
DM 4.64 11.83 11.03 5.00
ET 37.14 104.97 97.96 –
C. occidentalis R PE 74.48 95.24 107.43 –
DM 58.34 87.80 102.61 –
ET 19.54 76.25 101.53 –
L PE 9.83 33.77 62.97 –
DM 34.22 71.32 91.33- –
ET 64.22 69.16 76.96 –
M. oppositifolius L PE 10.74 42.13 90.75 –
DM 9.86 13.99 83.36 –
ET 93.49 91.99 99.04 –
R PE 44.01 71.36 89.19 –
DM 75.71 80.77 89.17 –
ET 13.15 46.49 86.99 –
P. amarus R PE 19.37 59.39 77.87 –
DM 78.74 86.98 99.43 –
ET 78.16 102.18 105.24 –
L PE 0 10.67 30.63 4.99
DM 12.20 44.06 53.53 –
ET 23.17 65.51 93.30 –
H. suaveolens R PE 9.48 34.59 99.74 –
DM 9.01 24.16 82.82 –
ET 90.73 99.81 104.91 –
L PE 0 0.47 7.26 2.54
DM 0 7.79 40.76 6.22
ET 42.86 71.00 80.41 –
A. vogelii R PE 3.84 14.29 23.28 9.59
DM 30.22 75.23 100.59 –
ET 96.00 101.03 105.57 –
C. alba R PE 13.75 64.70 76.10 –
DM 0 0 1.13 7.10
ET 14.85 61.77 81.89 –
M. lucida R PE 79.41 84.81 98.53 –
DM 19.05 36.55 48.13 13.37
ET 61.27 96.27 82.46 –
N. latifolia R PE 96.07 103.31 104.57 –
DM 59.84 95.28 104.70 –
ET 78.33 96.75 110.64 –
U. chamea R PE 77.99 96.84 99.10 –
DM 54.27 78.90 72.62 –
ET 95.88 102.46 85.21 –
Table 4: In vitro antiplasmodial activity of some extracts from Nigerian medicinal pants against P. falciparum D10 (CQs); L, leaves;
R, roots; PE, petroleum ether; DM, dichloromethane; ET, 80% ethanol
have focussed on its antiviral, antitumour, anticarcinogenic,
antimutagenic and anti-inflammatory properties. P. amarus is
also used to treat malaria in south-eastern Nigeria, where the
plant collection was done (Okafor and Ham 1999). Roots are
soaked in gin (alcoholic spirit distilled from grain or malt) and
taken to treat malaria. None of the root extracts including 80%
ET extracts exhibited significant antiplasmodial activity except
for the PE extracts of the leaves. Despite the antimalarial
activity of P. amarus, the traditional use of this plant does not
agree with the finding of this study. Traditionally, roots are
used, while polar solvent is used for extraction. Nevertheless,
P. amarus does possess antimalarial properties.
Another plant species that exhibited significant anti-
plasmodial activity was N. laevis. The DM extracts of its
roots showed antiplasmodial activity with IC50 of 5µg ml
–1.
Roots of N. laevis are known to contain lapachol — a
naphthaquinone (Houghton et al. 1994) that has also been
isolated from other species (Tabebuia heptaphylla and
Tecoma stans) belonging to the same family Bignoniaceae
(Guerra et al. 2001). Lapachol possesses antimalarial
activity (Carvalho et al. 1988) and this could explain the
antiplasmodial activity displayed by N. laevis. This is the
first time N. laevis has been reported to possess antiplas-
modial activity. Investigation is still continuing, to determine
if lapachol is the active compound or not.
The 80% ET extracts of P. nitida roots also showed
antiplasmodial activity, with an IC50 of 6.25µg ml
–1. Anti-
malarial properties of different parts of P. nitida have been
studied extensively (Iwu and Klayman 1992, Ezeamuzie et
al. 1994, Francois et al. 1996). However, the IC50 of 80%
ET extracts of the roots recorded in this study is much higher
than that reported by previous researchers. Francois et al.
(1996) reported an IC50 of 0.188µg ml
–1 for the root extract.
The dissimilarity in IC50 could be attributed to the difference
in the strain of the parasite used, as was evident in the work
of Iwu and Klayman (1992) where different IC50 values were
reported for the same extract on different clones of P.
falciparum. Some compounds, especially alkaloids (akua-
mmidine, akuammine, akuammicine, akuammigine and pseu-
doakuammigine), with pharmacological activity have been
isolated from P. nitida seeds (Menzies et al. 1998, Duwiejua
et al. 2002). However, none showed antimalarial activity,
although various solvent extracts from this plant exhibited
significant antimalarial activity. Further investigation is
needed towards isolating the anitmalarial compound(s).
In conclusion, this study has, to a considerable extent,
validated the traditional use of some of the plants studied.
The PE and DM extracts that exhibited both antibacterial
and anti-inflammatory activities could be due to the
presence of fatty acids. Ordinarily, PE and DM are used
for the removal of fatty acids (Cordell 1981). Antibacterial
and anti-inflammatory properties of fatty acids are well
known (Henry et al. 2002, McGaw et al. 2002). However,
further investigation is needed to establish whether the
activities are due to fatty acids or not, especially for those
plants in which the specific activity is reported for the first
time in this study. In the cases where antimalarial properties
have been established, the isolation of the antimalarial
agents is crucial. Toxicity studies are also needed to estab-
lish the safety of the active extracts.
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